MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?
MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of bi...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-09-01
|
| Series: | Clinical and Translational Radiation Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630820300689 |
| _version_ | 1818671666894471168 |
|---|---|
| author | A. Gomez-Iturriaga D. Büchser I. San Miguel M. Marban A. Urresola A. Ezquerro A. Gil F. Suarez A. Gonzalez E. Mairata L. Martinez-Indart J. Cacicedo F. Couñago P. Mínguez F. Casquero |
| author_facet | A. Gomez-Iturriaga D. Büchser I. San Miguel M. Marban A. Urresola A. Ezquerro A. Gil F. Suarez A. Gonzalez E. Mairata L. Martinez-Indart J. Cacicedo F. Couñago P. Mínguez F. Casquero |
| author_sort | A. Gomez-Iturriaga |
| collection | DOAJ |
| description | MRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases. |
| first_indexed | 2024-12-17T07:27:38Z |
| format | Article |
| id | doaj.art-600dde2f11414d31990be60fe4765883 |
| institution | Directory Open Access Journal |
| issn | 2405-6308 |
| language | English |
| last_indexed | 2024-12-17T07:27:38Z |
| publishDate | 2020-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Clinical and Translational Radiation Oncology |
| spelling | doaj.art-600dde2f11414d31990be60fe47658832022-12-21T21:58:34ZengElsevierClinical and Translational Radiation Oncology2405-63082020-09-0124135139MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes?A. Gomez-Iturriaga0D. Büchser1I. San Miguel2M. Marban3A. Urresola4A. Ezquerro5A. Gil6F. Suarez7A. Gonzalez8E. Mairata9L. Martinez-Indart10J. Cacicedo11F. Couñago12P. Mínguez13F. Casquero14Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, Spain; Corresponding author at: Department of Radiation Oncology, Hospital Universitario Cruces, Plaza Cruces Gurutzeta 12, 48903 Barakaldo, Spain.Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, Spain; Hospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Health Research Institute, Clinical Epidemiology Unit, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainDepartment of Radiation Oncology, Hospital Universitario Quirón salud Madrid, 28223 Pozuelo de Alarcón, Madrid, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainHospital Universitario Cruces/Biocruces Bizkaia Health Research Institute, Radiation Oncology, Barakaldo, SpainMRI-detected T3a prostate cancer is a heterogeneous disease. This post-hoc analysis of a prospective trial found that patients with T3a disease presenting obliteration of the recto-prostatic angle, contact-asymmetry of neuro-vascular bundle and periprostatic fat invasion, may be at higher risk of biochemical failure and metastases.http://www.sciencedirect.com/science/article/pii/S2405630820300689Prostate cancerRadiotherapyMultiparametric MRIExtraprostatic extensionBiochemical failureMetastases |
| spellingShingle | A. Gomez-Iturriaga D. Büchser I. San Miguel M. Marban A. Urresola A. Ezquerro A. Gil F. Suarez A. Gonzalez E. Mairata L. Martinez-Indart J. Cacicedo F. Couñago P. Mínguez F. Casquero MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? Clinical and Translational Radiation Oncology Prostate cancer Radiotherapy Multiparametric MRI Extraprostatic extension Biochemical failure Metastases |
| title | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
| title_full | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
| title_fullStr | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
| title_full_unstemmed | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
| title_short | MRI detected extaprostatic extension (EPE) in prostate cancer: Do all T3a patients have the same outcomes? |
| title_sort | mri detected extaprostatic extension epe in prostate cancer do all t3a patients have the same outcomes |
| topic | Prostate cancer Radiotherapy Multiparametric MRI Extraprostatic extension Biochemical failure Metastases |
| url | http://www.sciencedirect.com/science/article/pii/S2405630820300689 |
| work_keys_str_mv | AT agomeziturriaga mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT dbuchser mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT isanmiguel mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT mmarban mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT aurresola mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT aezquerro mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT agil mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT fsuarez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT agonzalez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT emairata mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT lmartinezindart mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT jcacicedo mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT fcounago mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT pminguez mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes AT fcasquero mridetectedextaprostaticextensionepeinprostatecancerdoallt3apatientshavethesameoutcomes |